The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
14-Apr-99
$1.3 billion
Target:
Berkshire Realty Company, Inc.
Acquiror:
Berkshire Chairman, Goldman Sachs and The Blackstone Group
Advised investor group led by Berkshire Realty Chairman, Goldman Sachs and The Blackstone Group on the buyout of Berkshire Realty, a multi-family REIT that owns 82 apartment communities located in Florida, Texas and the Mid-Atlantic and Southeastern US
16-Jun-99
$2.5 billion
Target:
TriNet Corporate Realty Trust, Inc.
Acquiror:
Starwood Financial Trust
Advised TriNet on a stock for stock merger with Starwood Financial, creating a leading player in the specialty real estate finance area
10-Aug-00
$750 million
Target:
Radisson Group, Inc.
Acquiror:
Olympus Real Estate Fund (Hicks, Muse)
(subsidiary of Carlson Companies, Inc.)
Advised Carlson Companies, Inc., the owner of the Radisson Hotels brand, on the formation of a $750 million Radisson Hotel acquisition fund, Radisson-Olympus Capital Partners.
11-Oct-01
$1.3 billion
Target:
Regal Cinemas, Inc.
Acquiror:
The Anschutz Corporation
Advised Regal Cinemas, the largest theatre chain in the United States, on its prepackaged bankruptcy plan and acquisition by The Anschutz Corporation
29-Aug-04
$3.8 billion
Target:
LNR Property Corporation
Acquiror:
Cerberus Capital Management, L.P.
Advised the Special Committee of the Board of Directors and the Board of Directors of LNR Property Corporation, one of the US’ leading real estate investment, finance and management companies, on its sale to Cerberus Capital Management, L.P. and its real estate affiliate, Blackacre Institutional Capital Management, LLC
01-Sep-05
$NA
Target:
Minit Group
Acquiror:
CVC Capital Partners
(wholly owned by UBS Capital)
Advised UBS Capital on its sale of the Minit Group, the world's largest shoe repair and key cutting services chain, to CVC Capital Partners
13-Sep-05
$NA
Target:
AEA Technology plc
Acquiror:
Coller Capital
Advised AEA Technology plc, a UK provider of Rail and Environmental services, on the sale of a portfolio of non-core businesses to Coller Capital. The sale formed part of a wider financial restructuring plan
20-Oct-05
$NA
Target:
Drakkar Holdings SA (Adisseo Group)
Acquiror:
China National Chemical Corporation
Advised CVC Capital Partners on the divestiture of Adisseo via the sale of Drakkar Holdings SA to China National BlueStar, a subsidiary of state-owned diversified chemicals company China National Chemical Corporation. Adisseo is a leading player in the animal nutrition market
06-Jan-06
$164 million
Target:
Acadia Realty Trust
Acquiror:
GDC Properties
(selected assets) Advised GDC Properties on its acquisition of a 77.8% interest in a one million square foot Wilmington, Delaware shopping center portfolio previously held by institutional investors in Acadia Realty Trust Fund I
24-Mar-06
$21.2 billion
Target:
Schering AG
Acquiror:
Bayer AG
Advised Bayer on its public offer for Schering, an international pharmaceuticals group based in Berlin, Germany
03-Aug-06
$6.0 billion
Target:
Reckson Associates Realty Corporation
Acquiror:
SL Green Realty Corporation
Advised the independent directors of Reckson, a real estate investment trust specializing in properties located in New York City and the surrounding Tri-State area, on the sale of Reckson to SL Green
10-Aug-06
$NA
Target:
Forest City Ratner
Acquiror:
Forest City Enterprises Inc.
Advised Forest City Enterprises, Inc. on the restructuring of its business relationship with its New York City affiliate Forest City Ratner
06-Nov-06
$4.2 billion
Target:
Kos Pharmaceuticals, Inc.
Acquiror:
Abbott Laboratories
Advised Kos Pharmaceuticals, Inc., a specialty pharmaceutical provider of cardiovascular and respiratory drugs, on its sale to Abbott Laboratories
25-Jan-07
$3.3 billion
Target:
Cardinal Health, Inc., Pharmaceutical Technologies and Services division
Acquiror:
The Blackstone Group
Provided fairness opinion to the board of directors of Cardinal Health, Inc., a global company serving the health-care industry, on the sale of its Pharmaceutical Technologies and Services business, which provides outsourced services and proprietary technologies to the global pharmaceutical and biotechnology industries
22-May-07
$6.5 billion
Target:
Crescent Real Estate Equities Company
Acquiror:
Morgan Stanley Real Estate
Advised Crescent Real Estate Equities Company, a REIT holding a diversified portfolio of office properties, hotels and resorts and luxury residential developments on its sale to Morgan Stanley Real Estate
04-Jun-07
$2.9 billion
Target:
Slough Estates USA (subsidiary of Slough Estates plc)
Acquiror:
Health Care Property Investors
Provided oversight of the process and an informal second opinion to the senior management of Slough Estates plc
05-Jul-07
$630 million
Target:
ALM Media Group Holdings, Inc.
Acquiror:
Incisive Media Ltd. (portfolio company of Apax Partners)
Advised Incisive Media, a portfolio company of Apax Partners, on the acquisition of ALM Media, a leading integrated media company focused on the legal and real estate sectors and the largest provider of B2B information to the US legal market
18-Jul-07
$NA
Target:
SF-Chem AG
Acquiror:
CABB GmbH
Sole advisor to CABB, a leading producer of monochloroacetic acid and related specialty intermediates, on the acquisition of SF-Chem, a manufacturer of chlorine and sulphur specialty intermediates
05-Nov-07
$3.4 billion
Target:
American Financial Realty Trust
Acquiror:
Gramercy Capital Corp.
Advised American Financial Realty Trust, a real estate investment trust that acquires properties from and leases properties to regulated financial institutions, on its sale to Gramercy Capital Corp., a commercial real estate specialty finance company
16-Nov-07
$203 million
Target:
Oakland Mall LLC
Acquiror:
California State Teachers' Retirement System and Urban Retail Properties
Advised the Kogan Family on the sale of Oakland Mall, a regional shopping mall in Troy, Michigan anchored by JC Penney, Sears and Macy's
22-Jan-08
$3.4 billion
Target:
Ventana Medical Systems, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment
12-Jun-08
$6.7 billion
Target:
Applied Biosystems Group
Acquiror:
Invitrogen Corporation
Provided fairness opinion to the Board of Directors of the Applera Corporation on the merger of its Applied Biosystems business, which serves the life science industry, with the Invitrogen Corporation, creating a global leader in biotechnology reagents and systems
01-Oct-08
$53 million
Target:
Biotage (Biosystems division)
Acquiror:
Qiagen NV
Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
23-Jun-09
$155 million
Target:
Monogram Biosciences, Inc.
Acquiror:
Laboratory Corporation of America Holdings
Advised LabCorp on the acquisition of Monogram Biosciences, a molecular diagnostics company focused on guiding and improving the treatment of serious infectious diseases and cancer